15 Best NASDAQ 100 Stocks to Buy Other Than SpaceX
SpaceX may be taking up more of the growth-stock conversation, but the NASDAQ-100 remains one of the main public-market baskets for investors looking at large-cap innovation.
Posts Tagged ‘NASDAQ:AMGN’
Top 10 NASDAQ Stocks to Buy for Retirement
Stocks rose after a highly anticipated Supreme Court ruling determined Federal Reserve Governor Lisa Cook would keep her position for the time being, refusing the Trump administration...
Amgen Inc. (AMGN) Price Target Raised to $303 After Q1 Model Update
TheFly reported on June 16 that Mizuho analyst Salim Syed increased the price target for AMGN to $303 from $295 while maintaining a Neutral rating on the shares.
10 Set-It-and-Forget-It Stocks to Buy Right Now
A peace pact agreed upon by the United States and Iran on June 18 helped ease concerns about inflation that had been weighing on markets.
10 Best Weight Loss Drug Stocks to Buy in 2026
The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
12 High Yield Fortune 500 Stocks to Buy Now
The 2026 Fortune 500 rankings dropped earlier this month, and it showed that collectively, these companies pulled in $21 trillion in revenue, a 5% increase from last year, while...
Is Amgen Inc. (AMGN) A Good Stock To Buy Now?
Is AMGN a good stock to buy? We came across a bullish thesis on Amgen Inc. on r/investing_discussion by Variant_Invest.
7 Best Longevity Stocks to Buy Now
Longevity stocks are getting more attention as investors look for companies tied to longer lifespans, healthier aging, and rising demand for care.
Top 10 Large Cap Value Stocks to Buy Now
On June 9, Tom Lee, Fundstrat Managing Partner, appeared on CNBC's 'Power Lunch' to discuss the latest market action.
10 Most Profitable Dividend Stocks to Invest In Now
A strong earnings season and continued optimism around artificial intelligence have helped keep US stocks on a solid footing.
Amgen Inc. (AMGN) Announces EC’s Grant of Marketing Authorization for IMDYLLTRA®
Amgen Inc. (NASDAQ:AMGN) is one of the best cheap stocks to buy for beginners. Amgen Inc.
10 Cheap NASDAQ Stocks to Buy Right Now
On April 28, Gabelli's John Belton joined CNBC's 'Closing Bell Overtime' to analyze the market environment heading into earnings season.
Louis Navellier’s Top 10 Long-Term Stock Picks
US stocks have advanced to record highs while shrugging off the lack of resolution in the US-Iran war and concerns over soaring inflation.
10 Best “Dogs of the Dow” Stocks to Buy for the Rest of 2026
A December 2025 report by CNBC highlighted that Kevin Simpson, founder and chief investment officer at Capital Wealth Planning, focused on five stocks tied to a strategy many ...
Baron Health Care Fund’s Performance Impacted by Amgen (AMGN) Omission
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here...
Amgen Inc. (NASDAQ:AMGN) Q1 2026 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for the Amgen Inc. Q1 2026 Earnings Conference Call.
Why Amgen Inc. (AMGN) is One of the Best Stem Cell Therapy Stocks to Buy
Amgen Inc. (NASDAQ:AMGN) is one of the best stem cell therapy stocks to buy. Canaccord initiated coverage of Amgen Inc.
8 Best Stem Cell Therapy Stocks to Buy
On April 23, Bankim Chadha, chief global strategist at Deutsche Bank, appeared on CNBC's ‘Money Movers’ to talk about uncertainty in the markets and what to expect with the...
Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead of Earnings
TheFly reported on April 9 that Guggenheim increased its price target on AMGN from $347 to $351 while maintaining a Neutral rating on the stock.
10 Most Undervalued Dow Stocks to Buy Now
The Dow Jones Industrial Average was established on May 26, 1896, as a straightforward benchmark to monitor market performance by author Charles Dow, who is a co-founder of Dow...
10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
13 NASDAQ Stocks with Highest Dividends
In recent years, technology markets have drawn more attention from investors around the world, especially those linked to the NASDAQ Composite Index.
7 Most Profitable Value Stocks to Buy Right Now
On April 2, Kevin Mahn, Hennion & Walsh Asset Management president and chief investment officer, joined 'Squawk Box' on CNBC to discuss market reactions to developments in the...
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks
In this article, we will discuss: Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks.
10 Most Profitable S&P 500 Stocks to Buy Now
Profitability has moved back to the center of the market conversation.
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position
Amgen Inc. (NASDAQ:AMGN) is also a staple in the 13F portfolio of Fisher Asset Management. The fund has held a small position in the company since early 2010.
Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies
On March 3, TheFly reported that Kyowa Kirin Co., Ltd.
11 Best Kid-Friendly Stocks to Invest In
By late 2025, long-term investing for children has expanded far beyond traditional college savings, evolving into a broader “cradle-to-retirement” financial planning approach...
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate
On February 27, 2026, Amgen Inc. (NASDAQ:AMGN)’s Phase 3 study (NCT05907122) saw an update.
10 Best Stocks to Invest in During a Recession
Geopolitical tensions are once again having a severe impact on the economic conditions and on investors' decisions in the market as well.
Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on AMGN.
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate
On February 20, Barclays initiated coverage of Amgen Inc. (NASDAQ:AMGN) with an Equal Weight rating and a $185 price target.
13 Best NASDAQ Dividend Stocks to Buy Now
In recent years, technology markets, especially those tracked by the NASDAQ Composite Index, have drawn growing attention from investors around the world.
Here’s What the Street is Saying About Amgen Inc. (AMGN)
Amgen Inc. (NASDAQ:AMGN) is one of the best immunotherapy stocks to buy according to hedge funds. On February 12, Amgen Inc.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN)
Amgen Inc. (NASDAQ:AMGN) is one of the best medical research stocks to buy according to hedge funds. Amgen Inc.
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under...
RBC Lifts Amgen (AMGN) Target After Strong Q4, Cites Key Drug Momentum
On February 4, RBC Capital raised its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $360 from $335.
15 Best Wide Moat Dividend Stocks to Invest in
Wide-moat stocks are companies with durable advantages that help them keep competitors at bay. According to an S&P Global report, a large market share can be a sign of a strong...
Amgen Inc. (NASDAQ:AMGN) Q4 2025 Earnings Call Transcript
Julianne: My name is Julianne, and I will be your conference facilitator today for the Amgen Inc. Q4 2025 Earnings Conference Call.
15 Stocks on Jim Cramer’s Recent Game Plan
Jim Cramer, the host of Mad Money, said on Friday that the stock market could be set up for a rebound this week if the largest companies set to report earnings come through with...
UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves
On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from $380 and kept a Buy rating on the stock.
12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds
The Dow Jones Industrial Average tracks 30 large, well-established companies across areas like finance, technology, and pharmaceuticals.
Bernstein Calls 2026 a “Waiting Year” for Amgen’s (AMGN) MariTide
On January 20, Bernstein downgraded Amgen Inc. (NASDAQ:AMGN) to Market Perform from Outperform, while leaving its $335 price target unchanged.
15 Best S&P 500 Dividend Stocks to Buy in 2026
Dividend stocks have often provided stability when markets get difficult.
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies
On January 13, 2026, an announcement came regarding the Ro and Amgen Inc. (NASDAQ:AMGN) collaboration. Ro, a U.S.
10 Undervalued Wide Moat Stocks to Buy Right Now
As U.S. markets go further into 2026, they are witnessing a shift in the macro backdrop that is reshaping expectations across asset classes. Following a sluggish 2025, U.S.
Hedge Fund Resource Center
